Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions
- Cervical Adenocarcinoma
- Cervical Adenosquamous Carcinoma
- Cervical Small Cell Carcinoma
- Cervical Squamous Cell Carcinoma
- Recurrent Cervical Carcinoma
- Stage III Cervical Cancer
- Stage IVA Cervical Cancer
- Stage IVB Cervical Cancer
Interventions
- BIOLOGICAL: Filgrastim
- OTHER: Laboratory Biomarker Analysis
- BIOLOGICAL: Pegfilgrastim
- DRUG: Topotecan Hydrochloride
- DRUG: Veliparib
Sponsor
National Cancer Institute (NCI)
Collaborators